FDA Inspection 1205651 — Medley Pharmaceuticals Limited
The FDA completed an inspection of Medley Pharmaceuticals Limited on May 19, 2023 in Daman. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 19, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Daman (India)